Modification of acrylamide neuropathy in rats by selected factors.
D000178:Acrylamides / Q000378:metabolism / Q000494:pharmacology*; D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000367:Age Factors; D000818:Animals; D003634:DDT / Q000494:pharmacology; D004790:Enzyme Induction / Q000187:drug effects; D006591:Hexobarbital; D006854:Hydrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D009043:Motor Activity / Q000187:drug effects; D009186:Myelin Sheath / Q000187:drug effects; D009474:Neurons / Q000166:cytology; D010088:Oxidoreductases / Q000378:metabolism; D010525:Peripheral Nerves / Q000187:drug effects* / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D013832:Thiamine Deficiency; D013997:Time Factors; D026681:Vitamin B 6 Deficiency
D000178:Acrylamides; D011335:Proadifen; D006591:Hexobarbital; D003634:DDT; D010088:Oxidoreductases; D006854:Hydrocortisone; D010634:Phenobarbital